What Sysmex Netherlands & Belgium does

Sysmex Netherlands & Belgium is the Benelux operating arm of Sysmex Corporation, structured as two regional subsidiaries (Sysmex Nederland B.V., headquartered in Etten-Leur, and Sysmex Belgium N.V., in La Hulpe) under Sysmex Europe SE. The business distributes and services a comprehensive in-vitro diagnostics portfolio to clinical laboratories, hospitals, blood banks, oncology centers, and government screening programs in the Netherlands and Belgium, employing approximately 180 staff.

The product platform is anchored by the XN-Series automated hematology analyzers, with proprietary software modules (Blood Bank Mode, Body Fluid Mode, PLT-F fluorescence platelet counting) and an Extended IPU enabling advanced parameters such as ICIS for sepsis screening and MDS-CBC for myelodysplastic syndrome detection. The Life Science portfolio includes the OSNA molecular diagnostic platform for intraoperative sentinel lymph node analysis, OncoBEAM RAS CRC liquid biopsy, SafeSEQ NGS-based ctDNA detection, the XF-1600 10-color flow cytometer, the DI-60 digital imaging system, and the Sentimag magnetic localization system. Adjacent offerings span hemostasis, urinalysis, clinical chemistry, point-of-care testing, veterinary diagnostics, and Industry & Research instrumentation distributed via a partnership with Malvern Panalytical.

Revenue is generated through three streams: capital equipment sales (hematology, flow cytometry, urinalysis analyzers), recurring reagents and consumables tied to the installed base, and multi-year service and maintenance contracts. The go-to-market is direct enterprise field sales combined with in-house technical support, preventive maintenance, and customer training delivered through Caresphere Academy. Customer engagement includes the Dutch National Colorectal Cancer Screening Programme using the SENTiFIT 270 analyzer and FOB Gold reagents, which has scaled to over 1.5 million participants.

Name

Sysmex Netherlands & Belgium

Legal name

Sysmex Nederland B.V.

Website

https://sysmex.nl

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Sysmex Netherlands & Belgium is the Benelux sales and service arm of Sysmex Corporation, distributing automated hematology analyzers, flow cytometry, urinalysis, molecular diagnostics, and life science platforms to clinical laboratories, hospitals, blood banks, and government screening programs in the Netherlands and Belgium.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

Medical Laboratories (621511), In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Hematology & Coagulation Diagnostics (HLAHAAAB)

akta.pro secondary industries

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA)

Keywords

• In-vitro diagnostics
• Hematology analyzers
• Clinical flow cytometry
• Molecular diagnostics
• Urinalysis systems

Headquarters

HQ city

Etten-Leur

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Equipment Sales: Sale of hematology analyzers, flow cytometers, urinalysis systems, and related diagnostic instrumentation to clinical laboratories and healthcare facilities.
2. Reagents and Consumables: Recurring revenue from specialized reagents, calibration solutions, and consumables required for Sysmex diagnostic analyzers operation.
3. Service and Maintenance Contracts: Technical support, preventive maintenance, breakdown service, and service contracts for diagnostic equipment installed at customer sites.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Sysmex Netherlands & Belgium sells and services automated in-vitro diagnostic analyzers (hematology, urinalysis, flow cytometry, hemostasis, fecal immunochemical testing), proprietary reagents and consumables, molecular diagnostic assays (OSNA, OncoBEAM, SafeSEQ), and related laboratory instrumentation to clinical laboratories, hospitals, blood banks, and public health screening programs across the Netherlands and Belgium. The company also provides technical support, preventive maintenance, breakdown service, and customer training through its Caresphere Academy platform.

Product overview

Sysmex Netherlands & Belgium offers a comprehensive portfolio of medical diagnostic solutions spanning In-Vitro Diagnostics (hematology, hemostasis, urinalysis, clinical chemistry, flow cytometry, point-of-care, veterinary diagnostics), Life Science products (OSNA molecular diagnostics for sentinel lymph node analysis, liquid biopsy solutions using BEAMing and SafeSEQ NGS technologies, digital pathology), and Industry & Research instruments (NIR spectrometers, particle analyzers, SEM). The product ecosystem centers on the XN-Series automated hematology analyzers with specialized software modules including Blood Bank Mode, Body Fluid Mode, and PLT-F fluorescence platelet counting. Key platforms include the XF-1600 flow cytometer, OSNA molecular diagnostic system, Sentimag magnetic localization system, and SENTiFIT 270 fecal immunochemical test analyzer. The company also provides laboratory equipment for environmental safety and extensive educational support through Caresphere Academy.

Differentiator

Problem solved

Functional benefit

Products and services

• XN-Series Hematology Analyzers Automated hematology analyzers (XN-1000, XN-2000, XN-550, XN-9000) providing complete blood counts, white blood cell differentials, and advanced diagnostic parameters for clinical laboratories.
• XE-5000 Hematology Analyzer Previous-generation automated hematology analyzer with body fluid mode for cerebrospinal fluid, pleural, peritoneal, and synovial fluid analysis.
• UF-5000 Urinalysis Analyzer Automated urine analyzer with body fluid mode capability for clinical urine and body fluid diagnostics.
• UN-Series Urinalysis Automated urinalysis system providing comprehensive urine testing with technology that reveals additional diagnostic information.
• XF-1600 Flow Cytometer 10-color flow cytometry platform with automation capabilities for clinical flow cytometry applications including lymphoproliferative syndrome diagnosis and B-CLL assessment.
• PS-10 Sample Preparation System Automated sample preparation system for flow cytometry providing standardized and reproducible sample processing.
• OSNA (One-Step Nucleic Acid Amplification) Molecular diagnostic assay for intraoperative sentinel lymph node analysis in breast, colorectal, gastric, gynecological, lung, and prostate cancers using CK19 mRNA detection.
• OncoBEAM RAS CRC Assay BEAMing-based liquid biopsy test for RAS mutation detection in circulating tumor DNA for metastatic colorectal cancer patients to guide anti-EGFR therapy decisions.
• SafeSEQ NGS Technology Next-generation sequencing technology for ultrasensitive circulating tumor DNA detection, minimal residual disease monitoring, and multi-analyte liquid biopsy applications across various cancers.
• Sentimag/Sienna+ System Magnetic sentinel lymph node localization system using superparamagnetic iron oxide nanoparticles as an alternative to radiotracer for breast and prostate cancer surgery.
• DI-60 Digital Imaging System Automated digital microscopy system for body fluid cell analysis and tumor cell detection, providing faster screening with accuracy comparable to manual microscopy.
• SENTiFIT 270 Analyzer Automated fecal immunochemical test (FIT) analyzer for quantitative determination of fecal hemoglobin in colorectal cancer screening programs.
• FOB Gold FIT Latex fecal immunochemical test for quantitative detection of fecal hemoglobin, used in population-based colorectal cancer screening programs.
• CALiaGold Calprotectin Assay Quantitative latex immunoassay for fecal calprotectin measurement on SENTiFIT 270 analyzer for IBD diagnosis and monitoring.
• NIR Spectrometers (Industry & Research) Near-infrared spectrometers for industrial and research applications including material analysis.
• Particle Size and Shape Analyzers Instruments from Malvern Panalytical for analyzing particle size distribution and particle shape characteristics in laboratory settings.
• SEM (Scanning Electron Microscopy) Scanning electron microscopy solutions for Industry & Research applications.
• Environmental & Safety Products Solutions including gas detection systems, acoustic cameras, air sampling equipment, fit testing, formaldehyde detection, and noise measurement for environmental monitoring and workplace safety.
• Veterinary Solutions In-vitro diagnostics solutions tailored for veterinary applications.
• Point-of-Care Testing Rapid diagnostic testing solutions for point-of-care settings.

Quantifiable outcome

• Dutch CRC screening program achieved 71.5% participation rate with over 1.5 million participants and 4.3% unfavorable FIT result rate
• +4 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature11 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Emerging players

• QIAGEN: Leading molecular diagnostics and sample-preparation vendor with QIAstat-Dx, digene HPV, and circulating tumor DNA assays. Competitor in liquid biopsy and companion diagnostics segments where Sysmex SafeSEQ and OncoBEAM operate.
• Mindray: Chinese IVD manufacturer rapidly expanding in Europe with BC-7500/BC-7600 hematology and chemiluminescence analyzers. Targets mid-tier and high-volume labs with lower-priced alternatives to Sysmex and Beckman Coulter.

Direct peers

• Sysmex Corporation: Japanese parent company that designs and manufactures the XN-series hematology, flow cytometry, urinalysis and molecular diagnostic platforms that Sysmex NL/BE sells. Direct strategic parent and obvious functional peer.
• Beckman Coulter (Danaher): Direct competitor in hematology and clinical chemistry IVD analyzers with deep installed base in European hospital labs. Comparable product menu (DxH series) and recurring reagent model.

Broad incumbents

• Roche Diagnostics: Global IVD leader with cobas hematology, clinical chemistry, immunoassay and molecular diagnostics suites. Serves the same NL/BE hospital and reference lab customers with a broader portfolio.
• bioMérieux: Specializes in microbiology and infectious disease diagnostics, with growing immunoassay and clinical flow cytometry presence. Overlaps with Sysmex in clinical lab diagnostics and to some extent in flow cytometry.
• Siemens Healthineers: Operates the Atellica and ADVIA Centaur hematology/chemistry/immunoassay lines plus extensive lab automation. Comparable enterprise sales motion to hospitals and reference labs in NL/BE.
• Abbott Diagnostics: Major IVD incumbent with CELL-DYN hematology, Alinity ci clinical chemistry/immunoassay, and molecular diagnostics. Competes head-to-head for hospital lab contracts across Benelux.

Regional players

• Hologic: Strong in women's health, oncology, and molecular diagnostics (e.g., Panther system). Overlaps with Sysmex's OSNA and liquid biopsy franchise in hospital oncology workflows.
• Ortho Clinical Diagnostics: Specializes in immunoassay and clinical chemistry (Vitros systems) with strong blood-bank screening presence. Overlaps with Sysmex in blood-bank QC and clinical chemistry adjacencies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sysmexbenelux

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sysmex Netherlands & Belgium